Clinical Trial Update: Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial update of a vaccine therapy plus interleukin-2, with or without interferon alfa-2b, in patients with Stage III melanoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)
• Interleukin-2 (interleukin-2)
• Vaccine therapy

Snippet

Sponsor: NYU Langone Health | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED